Zarxio acts on hematopoietic cells by binding to specific cell receptors and stimulating proliferation, differentiation commitment, and some end-cell functional activation. Growth colony stimulating ...
WASHINGTON, June 3 (Reuters) - Novartis AG unit Sandoz asked a U.S. appeals court on Wednesday to lift a preliminary injunction barring it from selling its biosimilar Zarxio, a cheaper version of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results